ALBAlbemarle Corporation
Albemarle Corporation (ALB) is a global leader in specialty chemicals, with a focus on lithium, bromine, and other industrial materials. The company’s next catalyst is Nov 4, 2026 — Q3 2026 Earnings Release, which will test its ability to sustain margins and deliver growth in a volatile market. The event will also provide clarity on the progress of its lithium business, which has been a key growth driver.
- Revenue fell 4.4% YoY to $5.81B, but free cash flow remained robust at $1.83B.
- Net margin of 11.4% reflects strong cost control amid softer demand.
- Debt-to-equity of 0.40x suggests a balanced capital structure, though leverage could rise if growth accelerates.
The schedule
- Wed4Nov
This earnings print will test the company's ability to maintain margins amid rising raw material costs and shifting demand in the lithium and specialty chemicals sectors. The outcome will also reflect the impact of recent price pressures and the company's strategic moves in the global supply chain.
- Tue9Feb
This report will provide further clarity on the company's long-term strategy in the lithium and specialty chemicals markets, as well as its ability to navigate supply chain disruptions and pricing pressures.
- Wed5May
This earnings print will be critical in assessing the company's ability to sustain its growth in the face of global supply chain challenges and evolving regulatory environments.
- Wed4Aug
This report will provide a comprehensive view of the company's performance in the second half of the year, including its ability to adapt to changing market conditions and maintain profitability.
Past
- Wed23Sep
Actual outcome: Bear · $105.85 at outcome
Stock fell 31.8% from event to outcome date, aligning with the bear trajectory.
Stock fell 31.8% from event to outcome date, aligning with the bear trajectory.
- Wed5Aug
Actual outcome: Bull · $131.79 at outcome
Stock rose 10.9% from event to outcome date, aligning with the bull trajectory.
Stock rose 10.9% from event to outcome date, aligning with the bull trajectory.
- Wed6May
Actual outcome: Bear · $175.74 at outcome
Albemarle delivered a strong Q1 report, beating earnings and revenue estimates driven by higher lithium pricing and a nearly 70% surge in Energy Storage sales. Despite an initial post-earnings rally and positive momentum sentiment, the stock failed to hold its gains and reversed sharply. Shares ultimately tumbled 16.4% by the outcome date, breaking well below the bear floor as the market likely took profits and digested valuation concerns following the initial surge.
Albemarle delivered a strong Q1 report, beating earnings and revenue estimates driven by higher lithium pricing and a nearly 70% surge in Energy Storage sales. Despite an initial post-earnings rally and positive momentum sentiment, the stock failed to hold its gains and reversed sharply. Shares ultimately tumbled 16.4% by the outcome date, breaking well below the bear floor as the market likely took profits and digested valuation concerns following the initial surge.
- Wed11Feb
Actual outcome: Bear · $156.70 at outcome
Albemarle reported Q4 2025 EPS of -$3.87, exactly matching consensus estimates, which highlighted ongoing severe pricing pressures in the broader lithium market. The stock fell 10.7% by the outcome date because the accompanying 2026 guidance failed to signal a near-term recovery in lithium demand or pricing. Without positive forward visibility or a catalyst for margin expansion, the market reacted bearishly to the prolonged fundamental weakness.
Albemarle reported Q4 2025 EPS of -$3.87, exactly matching consensus estimates, which highlighted ongoing severe pricing pressures in the broader lithium market. The stock fell 10.7% by the outcome date because the accompanying 2026 guidance failed to signal a near-term recovery in lithium demand or pricing. Without positive forward visibility or a catalyst for margin expansion, the market reacted bearishly to the prolonged fundamental weakness.
